# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001562762-23-000138
Filing Date
2023-03-27
Accepted
2023-03-27 16:07:31
Documents
18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | sava-20221231xdef14a.htm iXBRL | DEF 14A | 1857444
2 | GRAPHIC | sava-20221231xdef14ag001.jpg | GRAPHIC | 3888
3 | GRAPHIC | sava-20221231xdef14ag002.jpg | GRAPHIC | 22987
4 | GRAPHIC | sava-20221231xdef14ag003.jpg | GRAPHIC | 373243
5 | GRAPHIC | sava-20221231xdef14ag004.jpg | GRAPHIC | 464405
| Complete submission text file | 0001562762-23-000138.txt |  | 5000358

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | sava-20221231.xsd | EX-101.SCH | 8649
7 | EX-101.DEF | sava-20221231_def.xml | EX-101.DEF | 19415
8 | EX-101.LAB | sava-20221231_lab.xml | EX-101.LAB | 31049
9 | EX-101.PRE | sava-20221231_pre.xml | EX-101.PRE | 25839
12 | EXTRACTED XBRL INSTANCE DOCUMENT | sava-20221231xdef14a_htm.xml | XML | 277457

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29959 | Film No.: 23764615
SIC: 2834 Pharmaceutical Preparations